Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to 0.24%.

  • Maravai Lifesciences Holdings' Return on Capital Employed fell 800.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.2% for FY2024, which is 1800.0% down from last year.
  • Maravai Lifesciences Holdings' Return on Capital Employed amounted to 0.24% in Q3 2025, which was down 800.0% from 0.37% recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Return on Capital Employed ranged from a high of 0.33% in Q1 2022 and a low of 0.37% during Q2 2025
  • For the 5-year period, Maravai Lifesciences Holdings' Return on Capital Employed averaged around 0.06%, with its median value being 0.1% (2023).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Return on Capital Employed soared by 1800bps in 2022, and later crashed by -3300bps in 2025.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Return on Capital Employed stood at 0.31% in 2021, then fell by -13bps to 0.27% in 2022, then plummeted by -107bps to 0.02% in 2023, then tumbled by -1127bps to 0.22% in 2024, then fell by -10bps to 0.24% in 2025.
  • Its last three reported values are 0.24% in Q3 2025, 0.37% for Q2 2025, and 0.29% during Q1 2025.